alexa

GET THE APP

Anti-Psychotic Medication and the Pattern of Cardiovascular Risk Factors: A Population Based Study (The Ayrshire Diabetes Follow-Up Cohort (ADOC) Study)| Abstract
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Addict Res Ther 2017, Vol 8(7): 343
  • DOI: 10.4172/2155-6105.1000343

Anti-Psychotic Medication and the Pattern of Cardiovascular Risk Factors: A Population Based Study (The Ayrshire Diabetes Follow-Up Cohort (ADOC) Study)

Andrew Collier1*, Karthigayan Kessavalou2, Lee E Sit1, Mario Hair3, Lyall Cameron3 and Ammar Abdeen1
1Diabetes Day Centre, University Hospital Ayr, United Kingdom
2Department of Psychiatry, NHS Ayrshire and Arran, , Dalmellington Road, United Kingdom
3Department of Statistics, NHS Ayrshire and Arran, , Dalmellington Road, United Kingdom
*Corresponding Author : Andrew Collier, Consultant Physician and Honorary , Senior Lecturer, Diabetes Day Centre, University Hospital Ayr, United Kingdom, Tel: 01292 610555 Exn. 14314, Email: [email protected]

Received Date: Jul 07, 2017 / Accepted Date: Sep 19, 2017 / Published Date: Nov 26, 2017

Abstract

Background: Life expectancy in people with severe mental illness is significantly reduced: in part due to increased cardiac risk. Aim: The aims of this study were to investigate the prevalence of cardiovascular risk factors and to determine the prevalence of regular screening in these patients. Method: Data was extracted from 48 General Practices in NHS Ayrshire and Arran (n=320,613) in April 2015. Results: There were 3857 patients on anti-psychotic medication (prevalence 1.2%). Female patients and those on first generation medication were older (p<0.001). Monitoring rates ranged from 75% for BP and smoking down to under 50% for lipids. Only 10% of patients monitored were free of a cardiovascular risk factor. Conclusion: Treatment with anti-psychotic medication was associated with clustering of cardiovascular risk factors. Screening varied in relation to age and sex of the patient, the anti-psychotic agent prescribed and cardiovascular risk factor.

Keywords: Anti-psychotic medication; Obesity; Lifestyle; Hyperlipidaemia; Type 2 diabetes

Citation: Collier A, Kessavalou K, Sit LE, Hair M, Cameron L, et al. (2017) Anti-Psychotic Medication and the Pattern of Cardiovascular Risk Factors: A Population Based Study (The Ayrshire Diabetes Follow-Up Cohort (ADOC) Study). J Addict Res Ther 8: 343 Doi: 10.4172/2155-6105.1000343

Copyright: ©2017 Collier A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top